Free Disclosure Statement - District Court of Delaware - Delaware

Case 1:08-cv-00052-GMS-LPS

Document 66

Filed 04/01/2008

Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE __________________________________________ FOREST LABORATORIES, INC., et al., ) ) Plaintiffs, ) ) C.A. No. 08-52 (GMS) v. ) ) DR. REDDY'S LABORATORIES, INC., DR. ) REDDY'S LABORATORIES LIMITED, ) GENPHARM IC., GENPHARM, L.P., ) INTERPHARM HOLDINGS, INC., ) INTERPHARM, INC., MYLAN ) PHARMACETICALS INC., RANBAXY, INC., ) RANBAXY LABORATORIES LIMITED, ) KENDLE INTERNATIONAL INC., SUN INDIA ) PHARMACEUTICAL INDUSTRIES LIMITED ) (a/k/a SUN PHARMACEUTICAL INDUSTRIES ) LTD.), SYNTHON HOLDING B.V., SYNTHON ) B.V., SYNTHON LABORATORIES, INC., and ) SYNTHON PHARMACEUTICALS, INC. ) ) Defendants. ) __________________________________________)

DEFENDANT SYNTHON PHARMACEUTICALS, INC.'S RULE 7.1 STATEMENT Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, the undersigned counsel for Defendant Synthon Pharmaceuticals, Inc. (a nongovernmental corporate party) ("Synthon Pharms") makes the following disclosure statement: I. PARENT CORPORATIONS The parent corporation of Synthon Pharms is Synthon International Holding BV. The parent corporation of Synthon International Holding BV is Synthon Holding BV.

1

Case 1:08-cv-00052-GMS-LPS

Document 66

Filed 04/01/2008

Page 2 of 2

II.

PUBLICLY HELD COMPANIES OWNING 10% OR MORE OF SYNTHON PHARMS' STOCK As of March 31, 2008, no publicly held corporation owns 10% or more of Synthon

Pharms' stock. Dated: April 1, 2008 /s/ Elizabeth M. McGeever Elizabeth M. McGeever(# 2057) PRICKETT, JONES & ELLIOT, P.A. 1310 King Street Wilmington, DE 19899 Telephone: (302) 888-6500 Facsimile: (302) 658-8111 [email protected] Attorney for Defendants Synthon Holding B.V., Synthon B.V., Synthon Laboratories, Inc. and Synthon Pharmaceuticals, Inc. Of Counsel: E. Anthony Figg Joseph A. Hynds Lisa N. Phillips ROTHWELL, FIGG, ERNST & MANBECK, P.C. 1425 K Street, N.W. Suite 800 Washington, D.C. 20005 Telephone: (202) 783-6040 Facsimile: (202) 783-6031 [email protected] [email protected] [email protected]

2